Wow. It looks like all that capex over the last several years (perhaps helped by some synergies with Actrol) are starting to bear fruit. When I started purchasing REH, in October 2015, my thesis was that the equity base of the business was still under-utilised (thanks in large part to the musings of @madamswer). My fear, however, was that there was a risk that a structural change was occurring, resulting in a lower ROE as the new normal.
Adam, I owe you, again...
Wow. It looks like all that capex over the last several years...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add REH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$24.38 |
Change
0.660(2.78%) |
Mkt cap ! $18.39B | |||
| Open | High | Low | Value | Volume |
| $24.09 | $24.38 | $23.83 | $11.28M | 464.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11498 | $24.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $24.43 | 1975 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| REH (ASX) Chart |
